Stay updated with breaking news from Metabolic Disorders Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boehringer Ingelheim announced today that it has launched clinical development of its firstinclass IL11 inhibitor antibody BI 765423 with a Phase 1 study NCT05658107 to assess the safety tolerability and pharmacokinetics in healthy volunteers.
A preclinical study using stem cells to produce progenitor photoreceptor cells and then transplanting these into experimental models of damaged retinas has resulted in significant vision recovery.
Scientists at Duke-NUS Medical School in Singapore have uncovered a mechanism that leads to an advanced form of fatty liver disease-and it turns out that vitamin B12 and folic acid supplements could...
Scientists at Duke-NUS Medical School in Singapore have uncovered a mechanism that leads to an advanced form of fatty liver disease-;and it turns out that vitamin B12 and folic acid supplements could reverse this process.
Scientists at Duke-NUS Medical School in Singapore have uncovered a mechanism that leads to an advanced form of fatty liver disease -- and it turns out that vitamin B12 and folic acid supplements could reverse this process. These findings could...